1. Home
  2. BOW vs GHRS Comparison

BOW vs GHRS Comparison

Compare BOW & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$28.70

Market Cap

913.3M

Sector

Finance

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$12.61

Market Cap

892.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOW
GHRS
Founded
2020
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.3M
892.0M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
BOW
GHRS
Price
$28.70
$12.61
Analyst Decision
Buy
Strong Buy
Analyst Count
6
9
Target Price
$36.00
$30.11
AVG Volume (30 Days)
195.9K
256.4K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
42.10
N/A
EPS
1.53
N/A
Revenue
$519,241,000.00
N/A
Revenue This Year
$16.05
N/A
Revenue Next Year
$25.43
N/A
P/E Ratio
$18.76
N/A
Revenue Growth
33.44
N/A
52 Week Low
$23.50
$6.85
52 Week High
$42.29
$20.50

Technical Indicators

Market Signals
Indicator
BOW
GHRS
Relative Strength Index (RSI) 59.62 40.90
Support Level $27.97 $12.04
Resistance Level $28.95 $13.33
Average True Range (ATR) 0.86 0.79
MACD 0.15 -0.13
Stochastic Oscillator 85.88 19.50

Price Performance

Historical Comparison
BOW
GHRS

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: